Imaging technology in breast cancer detection has advanced rapidly, but clinical systems have not kept pace. Today, the biggest limitation in mammography is no longer how sharp images can be produced, but how effectively they can be used within real-world workflows. A perfect image means little if it cannot lead to a timely decision.
Mammography viewers are often presented as the next leap forward in breast cancer detection, and many clinical settings have already adopted them. However, they’re still mostly valued for improving image quality rather than solving workflow problems. Many hospitals and imaging centers continue to rely on inefficient systems that slow down diagnosis and add pressure to already busy teams. Without stronger workflow integration and practical usability, even the most advanced software risks becoming another expensive upgrade that improves technology, but not patient outcomes.
Clearer Images for Earlier Detection
Mia Barnes, Founder and Editor-in-Chief of Body+Mind
Globally, breast cancer is the most frequently diagnosed cancer. In 2022 alone, an estimated 2.3 million women were diagnosed, and 670,000 deaths were recorded, with delayed detection being a major factor. When cancer is found early and stays localized, the five-year survival rate can exceed 99%, according to the American Cancer Society.
Mammography remains among the most reliable screening tools, but it’s not without its limits. Detection can be more difficult in women with dense breast tissue, where abnormalities are harder to distinguish. The best breast imaging viewers can address this challenge primarily by improving image quality.
High-resolution rendering and DICOM-based imaging have been shown to produce lower image noise, higher brightness and greater uniformity compared to other formats. These improvements can make subtle abnormalities easier to detect, including in dense breast tissue.
However, focusing only on image clarity risks oversimplifying the problem. In many clinical settings, the challenge is consistently interpreting and acting on images within limited time and resources. A study found that as radiologists progress through a batch of images, they become slightly less likely to correctly identify cancer and more likely to miss a cancer. This means that while improved visualization is important and has helped many cases, it cannot deliver better outcomes on its own.
Faster Workflows Mean More Patients Screened
Breast cancer screenings dropped by as much as 61% during peak COVID-19 shutdowns in 2020, creating a backlog of missed or delayed diagnoses. Although screening volumes have begun to recover, the pace remains uneven, and healthcare systems continue to struggle to manage increased demand.
Many clinical settings now incorporate advanced mammography viewing software to address this problem. Thanks to faster loading times, automated hanging protocols and quick access to prior studies, staff can now reduce delays that interrupt the reading process. This can help increase the number of cases reviewed each day. However, faster workflows also raise concerns. If systems move too quickly without enough support for clinicians, there’s a risk of fatigue or missed details. This means that speed alone doesn’t guarantee better results.
Interoperability Remains Largely Unresolved
Breast imaging relies on multiple systems working together, including image storage, reporting and review. When these systems don’t connect well, delays can directly affect patient care. The best mammography viewers now offer interoperability. This means they can work with existing PACS and adhere to DICOM standards, making it easier for team members to access and share imaging data across departments.
In principle, this should allow clinicians to move between systems without disruption and collaborate more easily. The problem is that this level of integration is still not consistent in practice. Research suggests that seamless interoperability is still out of reach. Even with DICOM compliance, fragmented systems continue to create gaps. This points to a broader issue. Technology is advancing faster than healthcare systems can implement it.
Some Companies Are Already Closing the Implementation Gap
While much of the industry continues to prioritize feature development, some companies are already focusing more directly on the practical challenges of adoption — particularly workflow integration, system compatibility, and ease of use in high-volume clinical environments. For example, solutions developed by Candelis, Inc. focus on making high-volume imaging more manageable. Its tools help speed up access to prior studies and support large tomosynthesis datasets, which can have a big impact in busy screening environments where time is limited.
Similarly, Sectra brings imaging, communication, and workflow into one system. This can reduce the need to switch between platforms and help team members work more efficiently across departments. Meanwhile, Three Palm Software prioritizes consistency in how images are displayed. Standardized layouts can help reduce variation between reads and support more reliable interpretation.
These examples suggest that the path forward for companies wanting to offer the best breast imaging viewer is not solely about advancing imaging capabilities, but about making those capabilities easier to adopt and use in everyday clinical practice. Companies that focus on integration, usability and workflow alignment are likely to help improve real-world outcomes.
The Future, In Focus
The best mammography viewers are clearly improving breast cancer detection. They offer better images, faster workflows and more connected systems. But these advantages need to be evenly distributed across healthcare systems. That means the next phase of breast cancer detection will depend as much on interpretation and workflow as it does on imaging technology itself. If the industry continues to prioritize feature development without equal focus on integration, accessibility and workflow design, progress will remain incremental. The technology to improve breast cancer outcomes already exists; the work now is making sure it reaches every patient, in every clinical setting, not just the best-resourced ones.
Guest Byline
Mia Barnes — Founder and Editor-in-Chief of Body+Mind
Ms. Barnes is a professional researcher and freelance writer with over 5 years of experience. Mia’s expertise lies in healthcare innovations, technology, and medical advancements. Mia is also the Founder and Editor-in-Chief of Body+Mind magazine, an online health publication.
